Samsung Biologics establishes company’s first manufacturing presence in the USA by acquiring GSK’s manufacturing facility in Rockville, Maryland. The Rockville site comprises of two cGMP manufacturing plants with a combined 60,000-liter drug substance capacity and with this move, Samsung Biologics’ total global manufacturing capacity increases to 845,000 liters.
Read on